PROVECTUS BIOPHARMACEUTICALS, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount of $0 for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-30.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2016-03-30
- PROVECTUS BIOPHARMACEUTICALS, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2015 was $0.00.
- PROVECTUS BIOPHARMACEUTICALS, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2014 was $0.00.
- PROVECTUS BIOPHARMACEUTICALS, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- PROVECTUS BIOPHARMACEUTICALS, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2012 was $924.00K, a 50.00% decline from fiscal 2011.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 12 month |
|---|---|
| 2015-12-31 | $0.00 10-K · filed 2016-03-30 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-30 |
| 2013-12-31 | $0.00 10-K · filed 2016-03-30 |
| 2012-12-31 | $924.00K 10-K · filed 2015-03-12 |
| 2011-12-31 | $1.85M 10-K · filed 2014-03-13 |
| 2010-12-31 | $1.85M 10-K · filed 2013-03-14 |